Safety evaluation of genipin in Beagle dogs: acute and 28-day repeated oral toxicity studies
Abstract
IntroductionGenipin, a typical iridoid constituent derived from the fruits of Gardenia jasminoides Ellis, is an essential in vivo metabolite of geniposide. It exhibits diverse potent biofunctions, including hepatoprotection, anti-inflammation, neuroprotection, antioxidation, and glycolipid metabolism modulation. Nevertheless, the systemic toxicological profile of genipin remains insufficiently characterized, with particularly limited safety evidence from non-rodent models. This study aimed to evaluate the acute and subacute oral toxicity of genipin in Beagle dogs as a preclinical safety assessment.MethodsAcute toxicity was assessed using single oral doses of genipin at 29, 41, 59, 84, 120, and 140 mg/kg. For subacute toxicity, repeated-dose groups were administered 3, 9, and 27 mg/kg/day for 28 days. Clinical signs, body weight, food intake, hematology, clinical chemistry, urinalysis, electrocardiography, fecal occult blood, and histopathology were evaluated.ResultsThe results showed that the oral approximate lethal dose of genipin was 120.0–140.0 mg/kg, with doses ≥41 mg/kg inducing thymic, hepatorenal, and gallbladder toxicity. Repeated 27 mg/kg/day genipin caused gastrointestinal irritation, anemia, prolonged coagulation parameters, and toxicity to the hepatobiliary system, thymus, bone marrow, and gonads; 3 and 9 mg/kg/day genipin induced mild male gonad toxicity. Bone marrow toxicity and gastric mucosal irritation were fully reversible after recovery, while hepatic, thymic, and gonadal toxicity showed partial recovery.ConclusionThis study clarified the dose-toxicity relationship, major target organs, and toxic reversibility of genipin following oral exposure in non-rodent species. These findings provide robust preclinical toxicological evidence to support rational dosage optimization, risk assessment, and the safe use of genipin.
Related
- Safety Evaluation of Scutellaria baicalensis: Acute and 26-Week Repeated-Dose Oral Toxicity Studies in Rats.
- Design and Synthesis of New Thiazole Derivatives for Alzheimer’s Disease Therapy as a Potential Cholinesterase Inhibitor; Toxicity Prediction and Molecular Docking Studies and Biological Evaluation
- Acute and 90-Day Repeated-Dose Oral Toxicity of Urtica dioica L. Leaf Extract Granules in Rodents
- Has the prevalence of mental health problems of children and adolescents increased in recent 50 years? Systematic review and meta-analysis of repeated cross-sectional studies
- Pharmacogenetic Evidence in Opioid-Related Toxicity and Death with an Appraisal of Emerging Multi-Omics Studies: A Systematic Review
BibTeX
@article{meng2026safety,
title = {{Safety evaluation of genipin in Beagle dogs: acute and 28-day repeated oral toxicity studies}},
author = {Qianchao Meng and Wei Sun and Lijing Kang and Mingshu Huang and Taofen Wu and Yingmin Gu and Jianqiang Zhang and Zhili Cao and Fei Yang and Guangtao Yao},
journal = {Frontiers in Pharmacology},
year = {2026},
month = oct,
doi = {10.3389/fphar.2026.1924890},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1924890},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Safety evaluation of genipin in Beagle dogs: acute and 28-day repeated oral toxicity studies
AU - Qianchao Meng
AU - Wei Sun
AU - Lijing Kang
AU - Mingshu Huang
AU - Taofen Wu
AU - Yingmin Gu
AU - Jianqiang Zhang
AU - Zhili Cao
AU - Fei Yang
AU - Guangtao Yao
PY - 2026
DA - 2026/10/30
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1924890
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.1924890
AB - IntroductionGenipin, a typical iridoid constituent derived from the fruits of Gardenia jasminoides Ellis, is an essential in vivo metabolite of geniposide. It exhibits diverse potent biofunctions, including hepatoprotection, anti-inflammation, neuroprotection, antioxidation, and glycolipid metabolism modulation. Nevertheless, the systemic toxicological profile of genipin remains insufficiently characterized, with particularly limited safety evidence from non-rodent models. This study aimed to evaluate the acute and subacute oral toxicity of genipin in Beagle dogs as a preclinical safety assessment.MethodsAcute toxicity was assessed using single oral doses of genipin at 29, 41, 59, 84, 120, and 140 mg/kg. For subacute toxicity, repeated-dose groups were administered 3, 9, and 27 mg/kg/day for 28 days. Clinical signs, body weight, food intake, hematology, clinical chemistry, urinalysis, electrocardiography, fecal occult blood, and histopathology were evaluated.ResultsThe results showed that the oral approximate lethal dose of genipin was 120.0–140.0 mg/kg, with doses ≥41 mg/kg inducing thymic, hepatorenal, and gallbladder toxicity. Repeated 27 mg/kg/day genipin caused gastrointestinal irritation, anemia, prolonged coagulation parameters, and toxicity to the hepatobiliary system, thymus, bone marrow, and gonads; 3 and 9 mg/kg/day genipin induced mild male gonad toxicity. Bone marrow toxicity and gastric mucosal irritation were fully reversible after recovery, while hepatic, thymic, and gonadal toxicity showed partial recovery.ConclusionThis study clarified the dose-toxicity relationship, major target organs, and toxic reversibility of genipin following oral exposure in non-rodent species. These findings provide robust preclinical toxicological evidence to support rational dosage optimization, risk assessment, and the safe use of genipin.
SN - 1663-9812
ER -